Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study

Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial

(2017) Mahamadou S Sissoko et al.   LANCET INFECTIOUS DISEASES

Sterile protection against human malaria by chemoattenuated PfSPZ vaccine

(2017) Benjamin Mordmüller et al.   NATURE

Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

(2017) Kirsten E. Lyke et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Infectivity of Plasmodium falciparum in Malaria-Naive Individuals Is Related to Knob Expression and Cytoadherence of the Parasite

(2016) Danielle I. Stanisic et al.   INFECTION AND IMMUNITY

Chemically Attenuated Blood-Stage Plasmodium yoelii Parasites Induce Long-Lived and Strain-Transcending Protection

(2016) Amber I. Raja et al.   INFECTION AND IMMUNITY

Persistence and immunogenicity of chemically attenuated blood stage Plasmodium falciparum in Aotus monkeys

(2016) Sai Lata De et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY

Protection against malaria in mice is induced by blood stage–arrestinghistamine-releasing factor(HRF)–deficient parasites

(2016) Claudia Demarta-Gatsi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

(2016) Andrew S Ishizuka et al.   NATURE MEDICINE

Development of cultured Plasmodium falciparum blood-stage malaria cell banks for early phase in vivo clinical trial assessment of anti-malaria drugs and vaccines

(2015) Danielle I Stanisic et al.   MALARIA JOURNAL

Whole organism blood stage vaccines against malaria

(2015) Danielle I. Stanisic et al.   VACCINE

Cross-species malaria immunity induced by chemically attenuated parasites

(2013) Michael F. Good et al.   JOURNAL OF CLINICAL INVESTIGATION

Epidemiology of subpatent Plasmodium falciparum infection: implications for detection of hotspots with imperfect diagnostics

(2013) Jacklin F Mosha et al.   MALARIA JOURNAL

Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria Exposure

(2013) Ally Olotu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine

(2013) R. A. Seder et al.   SCIENCE

T cell-derived IL-10 and its impact on the regulation of host responses during malaria

(2012) Ana Paula Freitas do Rosario et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY

A real-time, quantitative PCR method using hydrolysis probes for the monitoring of Plasmodium falciparum load in experimentally infected human volunteers

(2011) Rebecca J Rockett et al.   MALARIA JOURNAL

Protection against Malaria by MSP3 Candidate Vaccine

(2011) Sodiomon B. Sirima et al.   NEW ENGLAND JOURNAL OF MEDICINE

Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice

(2010) Ahmed S. I. Aly et al.   CELLULAR MICROBIOLOGY

Cellular Tumor Necrosis Factor, Gamma Interferon, and Interleukin-6 Responses as Correlates of Immunity and Risk of Clinical Plasmodium falciparum Malaria in Children from Papua New Guinea

(2009) L. J. Robinson et al.   INFECTION AND IMMUNITY

Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells

(2009) T. Lindenstrom et al.   JOURNAL OF IMMUNOLOGY

Early Interferon‐γ Response againstPlasmodium falciparumCorrelates with Interethnic Differences in Susceptibility to Parasitemia between Sympatric Fulani and Dogon in Mali

(2009) Matthew B. B. McCall et al.   JOURNAL OF INFECTIOUS DISEASES

Protection against a Malaria Challenge by Sporozoite Inoculation

(2009) Meta Roestenberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya

(2009) Bernhards R. Ogutu et al.   PLoS One

A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali

(2009) Issaka Sagara et al.   VACCINE

Association of Early Interferon‐γ Production with Immunity to Clinical Malaria: A Longitudinal Study among Papua New Guinean Children

(2008) Marthe C. D’Ombrain et al.   CLINICAL INFECTIOUS DISEASES

Chemical Attenuation of Plasmodium berghei Sporozoites Induces Sterile Immunity in Mice

(2008) L. A. Purcell et al.   INFECTION AND IMMUNITY

Establishment of the 1st World Health Organization International Standard for Plasmodium falciparum DNA for nucleic acid amplification technique (NAT)-based assays

(2008) David J Padley et al.   MALARIA JOURNAL

Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge

(2008) Lisa A. Purcell et al.   VACCINE